Herpesvirus entry mediator
Herpesvirus entry mediator (HVEM), also known as TNFRSF14 (tumor necrosis factor receptor superfamily member 14), is a protein that in humans is encoded by the TNFRSF14 gene. It is a member of the tumor necrosis factor receptor superfamily and plays a key role in the entry of herpesvirus into cells.
Structure
The HVEM protein is a type I membrane protein that is expressed in many immune cells, including T cells, B cells, and monocytes. It consists of an extracellular domain containing four cysteine-rich repeats, a transmembrane domain, and a cytoplasmic domain that contains a death domain motif.
Function
HVEM acts as a receptor for herpes simplex virus (HSV) and pseudorabies virus (PRV), facilitating their entry into cells. It interacts with the viral glycoprotein D (gD), which is present on the surface of the virus. This interaction triggers a series of events that lead to the fusion of the viral envelope with the cell membrane, allowing the virus to enter the cell.
In addition to its role in viral entry, HVEM also plays a role in immune regulation. It can interact with several ligands, including LIGHT and BTLA, to modulate immune responses. For example, the interaction between HVEM and BTLA can inhibit T cell activation, providing a mechanism for immune tolerance.
Clinical significance
Mutations in the TNFRSF14 gene can lead to a variety of immune disorders. For example, loss-of-function mutations have been associated with an increased risk of autoimmune diseases, such as rheumatoid arthritis and lupus. On the other hand, gain-of-function mutations can lead to the development of certain types of cancer, including non-Hodgkin lymphoma and cutaneous T cell lymphoma.
Research
Research is ongoing to develop drugs that can block the interaction between HVEM and its ligands, with the aim of preventing herpesvirus infection or modulating immune responses. Several small molecule inhibitors and monoclonal antibodies are currently in preclinical or early clinical development.
See also
References
<references />
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
